These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 24789435)

  • 1. Prognostic factors for desmoid tumor: a surgical series of 233 patients at a single institution.
    Zeng WG; Zhou ZX; Liang JW; Hou HR; Wang Z; Zhou HT; Zhang XM; Hu JJ
    Tumour Biol; 2014 Aug; 35(8):7513-21. PubMed ID: 24789435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients.
    Peng PD; Hyder O; Mavros MN; Turley R; Groeschl R; Firoozmand A; Lidsky M; Herman JM; Choti M; Ahuja N; Anders R; Blazer DG; Gamblin TC; Pawlik TM
    Ann Surg Oncol; 2012 Dec; 19(13):4036-42. PubMed ID: 22972507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors for the recurrence of sporadic desmoid-type fibromatosis after macroscopically complete resection: Analysis of 114 patients at a single institution.
    He XD; Zhang YB; Wang L; Tian ML; Liu W; Qu Q; Li BL; Hong T; Li NC; Na YQ
    Eur J Surg Oncol; 2015 Aug; 41(8):1013-9. PubMed ID: 26005133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series.
    Mullen JT; Delaney TF; Kobayashi WK; Szymonifka J; Yeap BY; Chen YL; Rosenberg AE; Harmon DC; Choy E; Yoon SS; Raskin KA; Petur Nielsen G; Hornicek FJ
    Ann Surg Oncol; 2012 Dec; 19(13):4028-35. PubMed ID: 22965569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary and recurrent sporadic desmoids: Prognostic factors influencing recurrence-free survival after complete gross resection.
    Mueller C; Croner R; Klein P; Grützmann R; Vassos N
    Int J Surg; 2016 Jul; 31():63-70. PubMed ID: 27262879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution.
    Huang K; Fu H; Shi YQ; Zhou Y; Du CY
    J Surg Oncol; 2009 Dec; 100(7):563-9. PubMed ID: 19722232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study.
    Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A
    Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of prognostic factors affecting recurrences and disease-free survival in extra-abdominal desmoid tumors].
    Ozger H; Eralp L; Toker B; Ağaoğlu F; Dizdar Y
    Acta Orthop Traumatol Turc; 2007; 41(4):291-4. PubMed ID: 18180559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical treatment of pediatric desmoid tumors. A 12-year, single-center experience.
    Soto-Miranda MA; Sandoval JA; Rao B; Neel M; Krasin M; Spunt S; Jenkins JJ; Davidoff AM; Ver Halen JP
    Ann Surg Oncol; 2013 Oct; 20(11):3384-90. PubMed ID: 23838914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors influencing event-free survival and treatments in desmoid-type fibromatosis: analysis from a large institution.
    Huang K; Wang CM; Chen JG; Du CY; Zhou Y; Shi YQ; Fu H
    Am J Surg; 2014 Jun; 207(6):847-54. PubMed ID: 24119719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical prognostic factors for pediatric extra-abdominal desmoid tumor: analyses of 66 patients at a single institution.
    Ning B; Jian N; Ma R
    World J Surg Oncol; 2018 Dec; 16(1):237. PubMed ID: 30563530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local recurrence after surgery for primary extra-abdominal desmoid-type fibromatosis.
    van Broekhoven DL; Verhoef C; Elias SG; Witkamp AJ; van Gorp JM; van Geel BA; Wijrdeman HK; van Dalen T
    Br J Surg; 2013 Aug; 100(9):1214-9. PubMed ID: 23804156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of local recurrence after surgery in extraabdominal desmoid-type fibromatosis: A multicenter study in Japan.
    Nishida Y; Hamada S; Kawai A; Kunisada T; Ogose A; Matsumoto Y; Ae K; Toguchida J; Ozaki T; Hirakawa A; Motoi T; Sakai T; Kobayashi E; Gokita T; Okamoto T; Matsunobu T; Shimizu K; Koike H
    Cancer Sci; 2020 Aug; 111(8):2935-2942. PubMed ID: 32539220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Management of Desmoid Tumors: A Retrospective Study of 30 Cases.
    Zenzri Y; Yahyaoui Y; Charfi L; Ghodhbani Z; Letaief F; Ayadi M; Mezlini A
    Int J Surg Oncol; 2020; 2020():9197216. PubMed ID: 32733704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis.
    Crago AM; Denton B; Salas S; Dufresne A; Mezhir JJ; Hameed M; Gonen M; Singer S; Brennan MF
    Ann Surg; 2013 Aug; 258(2):347-53. PubMed ID: 23532110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution.
    Gronchi A; Casali PG; Mariani L; Lo Vullo S; Colecchia M; Lozza L; Bertulli R; Fiore M; Olmi P; Santinami M; Rosai J
    J Clin Oncol; 2003 Apr; 21(7):1390-7. PubMed ID: 12663732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extra-abdominal desmoid fibromatosis: An evaluation of clinical factors affecting local recurrence rates.
    Coşkun HS; Erdoğan F; Çinka H; Dabak N
    Acta Orthop Traumatol Turc; 2021 Dec; 55(6):547-551. PubMed ID: 34967745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies.
    Bishop AJ; Landry JP; Roland CL; Ratan R; Feig BW; Moon BS; Zarzour MA; Wang WL; Lazar AJ; Lewis VO; Torres KE; Guadagnolo BA
    Cancer; 2020 Jul; 126(14):3265-3273. PubMed ID: 32343846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROMIS Function Scores Are Lower in Patients Who Underwent More Aggressive Local Treatment for Desmoid Tumors.
    Newman ET; Lans J; Kim J; Ferrone M; Ready J; Schwab J; Raskin K; Calderon SL
    Clin Orthop Relat Res; 2020 Mar; 478(3):563-577. PubMed ID: 31429829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors influencing progression-free survival determined from a series of sporadic desmoid tumors: a wait-and-see policy according to tumor presentation.
    Salas S; Dufresne A; Bui B; Blay JY; Terrier P; Ranchere-Vince D; Bonvalot S; Stoeckle E; Guillou L; Le Cesne A; Oberlin O; Brouste V; Coindre JM
    J Clin Oncol; 2011 Sep; 29(26):3553-8. PubMed ID: 21844500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.